BNTX

#542
BioNTech SE American Depositary Share
96.27 USD
-0.44%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
96.14
96.65
년간 변동
79.52
123.98
일일 변동
-0.44%
월간 변동
+4.64%
6달 변화
-6.06%
년간 변동율
-5.89%
이전 종가
96.70
Open
96.39
Bid
Ask
Low
96.14
High
96.65
양
64
Open full chart

Financials

Overview 성명 Statistics Dividends
Quarterly Annual
  • Market Capitalization 23.1 B
  • Employee 7 807
  • Founded 2008
  • CEO Uğur Şahin
  • Website www.biontech.de
  • Headquarter Germany
  • FIGI BBG00Q70B3V1
  • Industry Technology

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

뉴스